On the recordDecember 7, 2011
Thank you, Chairman. Mr. Speaker, I recently coauthored a letter with my colleagues, Representative Sandy Adams and Representative Trey Gowdy, concerning this very issue, and I'd like to read just a paragraph: ``As of October 4, 2011, the DEA has 325 researchers conducting research with Schedule I controlled substances. These researchers include research centers and universities who seek to better understand the effects of Schedule I controlled substances. Additionally, as of October 4, 2011, the DEA has 3,983 active registrants who manufacture, research, and conduct chemical analysis with Schedule I controlled substances. ``In fact, many researchers who would conduct research to better understand the compounds controlled in H.R. 1254 are already registered with the DEA, which means there would be virtually no impact on ongoing research.'' Mr. Speaker, as a former prosecutor for 18 years at the State and local level, I have seen firsthand the disaster this drug causes. The SPEAKER pro tempore. The time of the gentleman has expired.
